Tenax Therapeutics News and Activities

Tenax Therapeutics is a company listed under the stock ticker TENX (US).

View the org chart displaying its 14 main executives

Most searched biographies at Tenax Therapeutics

• Christopher Giordano, Chief Executive Officer and Director
• Robyn Hunter, Director
• Gerald Proehl, Chairman of the Board

Popular executive movements at Tenax Therapeutics

• So-Young Kim has joined the company as Executive Vice President, Clinical Development and Strategy  (posted on June 1 2026).
• Timothy Healey has joined the company as Chief Commercial Officer  (posted on May 5 2026).
• Thomas Staab will join the company as Chief Financial Officer on May 11, 2026  (posted on April 22 2026).

Click here to view some more movements at Tenax Therapeutics

Create your alert
to follow the executive moves at Tenax Therapeutics.

Tenax Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Tenax Therapeutics

• News Releases | Tenax Therapeutics
• News Releases | Tenax Therapeutics
• Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Fri, 05/08/2026 - 16:05
• Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Tue, 05/12/2026 - 07:00
• Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer | Mon, 05/04/2026 - 07:00
• Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer | Wed, 04/22/2026 - 07:00
• Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update | Tue, 03/10/2026 - 07:00
• Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference | Tue, 03/03/2026 - 07:00
• News Releases | Tenax Therapeutics
• Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 | Wed, 02/04/2026 - 07:00
• View more press releases Close

Social media about Tenax Therapeutics

• Tenax Therapeutics on Wikipedia, Google News & Yahoo Finance
• Tenax Therapeutics on LinkedIn, X (Twitter) & YouTube